COVID-19 与重症肌无力。
COVID-19 in patients with myasthenia gravis.
机构信息
Department of Neurology, Boston University Medical Center, Boston, Massachusetts.
Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
Abstract
INTRODUCTION
Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic, but little is known about its potential impact on patients with myasthenia gravis (MG).
METHODS
We studied the clinical course of COVID-19 in five hospitalized patients with autoimmune MG (four with acetylcholine receptor antibodies, one with muscle-specific tyrosine kinase antibodies) between April 1, 2020-April 30-2020.
RESULTS
Two patients required intubation for hypoxemic respiratory failure, whereas one required significant supplemental oxygen. One patient with previously stable MG had myasthenic exacerbation. One patient treated with tocilizumab for COVID-19 was successfully extubated. Two patients were treated for MG with intravenous immunoglobulin without thromboembolic complications.
DISCUSSION
Our findings suggest that the clinical course and outcomes in patients with MG and COVID-19 are highly variable. Further large studies are needed to define best practices and determinants of outcomes in this unique population.
摘要
简介
2019 年冠状病毒病（COVID-19）迅速成为一种全球性大流行病，但人们对其对重症肌无力（MG）患者的潜在影响知之甚少。
方法
我们研究了 2020 年 4 月 1 日至 4 月 30 日期间五例住院自身免疫性 MG 患者（四例乙酰胆碱受体抗体阳性，一例肌肉特异性酪氨酸激酶抗体阳性）COVID-19 的临床过程。
结果
两名患者因低氧性呼吸衰竭需要插管，而一名患者需要大量补充氧气。一名先前病情稳定的 MG 患者出现肌无力危象。一名接受托珠单抗治疗 COVID-19 的患者成功拔管。两名患者因 COVID-19 接受静脉注射免疫球蛋白治疗，无血栓并发症。
讨论
我们的研究结果表明，MG 和 COVID-19 患者的临床过程和结局高度可变。需要进一步的大型研究来确定这一特殊人群的最佳治疗方法和结局决定因素。
相似文献
1
COVID-19 in patients with myasthenia gravis.COVID-19 与重症肌无力。
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
2
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.新型冠状病毒肺炎与重症肌无力全身型加重：一例报告
Clin Neurol Neurosurg. 2020 Sep;196:106045. doi: 10.1016/j.clineuro.2020.106045. Epub 2020 Jun 25.
3
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.新型冠状病毒肺炎（COVID-19）大流行期间重症肌无力（MG）和兰伯特-伊顿肌无力综合征（LEMS）的管理指南。
J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.
4
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.回顾性分析高流量鼻导管通气在 COVID-19 相关中重度低氧血症性呼吸衰竭中的应用。
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000650.
5
Description of 3 patients with myasthenia gravis and COVID-19.描述 3 例重症肌无力和 COVID-19 患者。
J Neurol Sci. 2020 Oct 15;417:117053. doi: 10.1016/j.jns.2020.117053. Epub 2020 Jul 22.
6
Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.一名感染新冠病毒的儿童出现高炎症综合征，经静脉注射免疫球蛋白和托珠单抗成功治愈。
Indian Pediatr. 2020 Jul 15;57(7):681-683. doi: 10.1007/s13312-020-1901-z. Epub 2020 May 10.
7
A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure.对避免对患有新型冠状病毒肺炎相关呼吸衰竭的严重低氧血症患者进行系统性插管的呼吁。
Crit Care. 2020 Jun 12;24(1):337. doi: 10.1186/s13054-020-03063-6.
8
Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.临床推理：新型冠状病毒肺炎感染所致重症肌无力危象的治疗考量
Neurology. 2020 Nov 3;95(18):840-843. doi: 10.1212/WNL.0000000000010651. Epub 2020 Aug 14.
9
Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.COVID-19 合并低氧性急性呼吸衰竭患者俯卧位通气的应用。
JAMA. 2020 Jun 9;323(22):2336-2338. doi: 10.1001/jama.2020.8255.
10
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.COVID-19 合并难治性重症肌无力：成功治疗 1 例报告
J Neuromuscul Dis. 2020;7(3):361-364. doi: 10.3233/JND-200520.
引用本文的文献
1
Evaluation of Clinical Effects of COVID-19 Infection and Vaccines on Myasthenia Gravis.新型冠状病毒肺炎感染及疫苗对重症肌无力临床影响的评估
Noro Psikiyatr Ars. 2024 Aug 19;67(3):213-220. doi: 10.29399/npa.28418. eCollection 2024.
2
Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective study.新冠病毒感染合并重症肌无力患者的临床特征：一项真实世界的回顾性研究。
Front Public Health. 2024 Aug 27;12:1421211. doi: 10.3389/fpubh.2024.1421211. eCollection 2024.
3
Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.重症肌无力与2019冠状病毒病：一项系统评价与荟萃分析
Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.
4
COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China.中国单中心回顾性研究：COVID-19 合并重症肌无力患者。
Neurol Sci. 2024 Jul;45(7):2969-2976. doi: 10.1007/s10072-024-07518-4. Epub 2024 Apr 23.
5
Myasthenia gravis and coronavirus disease 2019: A report from Iran.重症肌无力与2019冠状病毒病：来自伊朗的报告。
Curr J Neurol. 2021 Jul 6;20(3):162-165. doi: 10.18502/cjn.v20i3.7692.
6
COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy.新型冠状病毒肺炎：吉兰-巴雷综合征、重症肌无力和小纤维神经病变的现代诱发因素
Front Neurosci. 2023 Aug 30;17:1198327. doi: 10.3389/fnins.2023.1198327. eCollection 2023.
7
Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions.重症肌无力：从传统治疗到再生治疗干预的新发现与展望
Aging Dis. 2023 Aug 1;14(4):1070-1092. doi: 10.14336/AD.2022.1215.
8
A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection.新冠病毒感染后新发重症肌无力的病例报告及文献综述
Cureus. 2022 Dec 28;14(12):e33048. doi: 10.7759/cureus.33048. eCollection 2022 Dec.
9
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.COVID-19 症状和治疗在自身免疫性疾病中的全面综述。
Virol J. 2023 Jan 7;20(1):1. doi: 10.1186/s12985-023-01967-7.
10
New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies.重症肌无力的新型靶向药物及未来治疗策略
J Clin Med. 2022 Oct 28;11(21):6394. doi: 10.3390/jcm11216394.
本文引用的文献
1
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.新型冠状病毒肺炎后急性脑血管病：一项单中心、回顾性、观察性研究。
Stroke Vasc Neurol. 2020 Sep;5(3):279-284. doi: 10.1136/svn-2020-000431. Epub 2020 Jul 2.
2
First cases of COVID-19 in heart transplantation from China.中国心脏移植中首例新冠病毒病病例。
J Heart Lung Transplant. 2020 May;39(5):496-497. doi: 10.1016/j.healun.2020.03.006. Epub 2020 Mar 17.
3
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
4
Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020.2020年4月初，在洛杉矶市中心一名感染新冠病毒的年轻女性患者中发生了无呼吸衰竭的脑膜脑炎。
Brain Behav Immun. 2020 Jul;87:33. doi: 10.1016/j.bbi.2020.04.024. Epub 2020 Apr 17.
5
Encephalitis as a clinical manifestation of COVID-19.脑炎作为新型冠状病毒肺炎（COVID-19）的一种临床表现。
Brain Behav Immun. 2020 Aug;88:945-946. doi: 10.1016/j.bbi.2020.04.017. Epub 2020 Apr 10.
6
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.首例与 SARS-CoV-2 相关的脑膜炎/脑炎。
Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3.
7
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.新型冠状病毒肺炎（COVID-19）大流行期间重症肌无力（MG）和兰伯特-伊顿肌无力综合征（LEMS）的管理指南。
J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.
8
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.新型冠状病毒肺炎相关急性出血性坏死性脑病：影像学特征
Radiology. 2020 Aug;296(2):E119-E120. doi: 10.1148/radiol.2020201187. Epub 2020 Mar 31.
9
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
10
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?COVID-19 于肾移植受者中的病例报告：免疫抑制是否改变临床特征？
Am J Transplant. 2020 Jul;20(7):1875-1878. doi: 10.1111/ajt.15874. Epub 2020 Apr 9.
Zotero 插件